sciencenewsnet.in

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

March 4, 2021 sarah Jonas Corona, Coronavirus, covid, COVID-19, Emergency Use Authorization, face shields, FDA, Health, Health Care, Johnson & Johnson, Medical, Medicine, Minorities, Minority Populations, nasopharyngeal swabs, National Institutes of Health, New Jersey, NIH, NJ, Pandemic, personal protective equipment, PPE, Public Health, Research, RU, RUCDR Infinite Biologics, Rutgers, Rutgers Biomedical and Health Sciences, Rutgers New Jersey Medical School, Rutgers Robert Wood Johnson Medical School, Rutgers School of Public Health, Rutgers University, Rutgers University-Camden, Rutgers University-New Brunswick, Rutgers University-Newark, saliva test, SARS-CoV-2, Science, swabs, U.S. Food And Drug Administration, Underserved Communities, Underserved Populations, University Hospital, Vaccination, Vaccines

The last year, which has been unlike any other in Rutgers’ 254-year history, has centered on keeping the Rutgers community safe, providing top-notch health care, developing the first saliva test for the coronavirus and helping society cope with the biggest global public health crisis since the 1918 influenza pandemic.

sciencenewsnet.in

Johnson & Johnson

6 important things to know about your COVID-19 vaccine card

A Johns Hopkins University health care expert is available to offer perspective on the news that a mistake at a Johnson & Johnson factory producing the COVID-19 vaccine resulted in the loss of millions of doses.

FAU Expert Answers Questions about COVID-19 Vaccines

Behind the Scenes at a COVID-19 Vaccine Trial

Rutgers University’s Resilient, Innovative Year Confronting COVID-19

Johnson & Johnson Seeks FDA Emergency Use Authorization for COVID-19 Vaccine

American Dental Hygienists’ Association Teams Up with Walgreens and Johnson & Johnson for National Dental Hygiene Month